In line with this, Cawley et al. found that abnormal LAMP1 glycosylation might contribute significantly to NPC progression, with high glycosylation levels of LAMP1 detected in both Npc−/− mice and NPC patients [128]. The gene discussed is LAMP1; the disease is nasopharyngeal carcinoma.